AstraZeneca to acquire Alexion EP News Bureau Dec 12, 2020 Subject to approvals, the acquisition is expected to close in Q3 2021
New therapies will overcome unmet needs in hepatocellular carcinoma: GlobalData EP News Bureau Dec 11, 2020 They have different mechanisms of action and are aiming to meet needs in different treatment settings
Alembic Pharma gets USFDA final approval for Asenapine Sublingual Tablets EP News Bureau Dec 11, 2020 Asenapine is an atypical antipsychotic indicated for bipolar I disorder as adjunctive treatment to lithium or valproate in adults
Gilead Sciences to acquire MYR GmbH EP News Bureau Dec 10, 2020 Gilead to acquire Hepcludex, a first-in-class entry inhibitor, for treatment of chronic hepatitis delta virus (HDV), after closing…
SeQuent launches Citramox LA in ten European countries EP News Bureau Dec 10, 2020 It is an antibiotic indicated for the treatment of respiratory infections caused by Mannheimia haemolytica and Pasteurella…
Snowman Logistics and Spicejet sign MoU for COVID-19 vaccines distribution EP News Bureau Dec 10, 2020 Snowman will handle the ground services while Spicejet provide the air connectivity for temperature-controlled distribution,…
Pharma industry seeks support from the government on MEIS Usha Sharma Dec 10, 2020 MEIS will be available to exporters only up to December 31, 2020, it is getting replaced with RoDTEP
Boehringer Ingelheim to acquire Labor Dr Merk & Kollegen EP News Bureau Dec 9, 2020 Transaction expands Boehringer Ingelheim’s R&D and clinical manufacturing capabilities with a site focused predominantly on…
Dr Reddy’s announces secondary listing of ADRs on NSE IFSC, GIFT City, Gujarat EP News Bureau Dec 9, 2020 This is a secondary listing of ADRs that are currently issued by J.P. Morgan Chase Bank NA under its ADR Deposit agreement with Dr…
USFDA grants Zydus fast track designation for Saroglitazar to treat primary biliary cholangitis EP News Bureau Dec 9, 2020 Zydus announced that the United States Food and Drug Administration (USFDA) has granted ‘Fast Track Designation’ to Saroglitazar…
Piramal Pharma Solutions invests ~$32 mn in its Riverview Michigan facility EP News Bureau Dec 9, 2020 It will expand existing capacities and build new capabilities for the development and manufacturing of APIs
Aurobindo gets USFDA nod for dexmedetomidine HCL in 0.9% sodium chloride injection EP News Bureau Dec 9, 2020 The product will be launched in January 2021
Aesthetic injectables market in APAC to reach $3.8 billion in 2030: GlobalData EP News Bureau Dec 8, 2020 The growth is drive by an increasing number of aesthetic procedures, technological advancements, growing urban population,…
GenNext at SIRO Clinpharm Viveka Roychowdhury Dec 7, 2020 SIRO, one of India’s earliest CROs, is set to scale new heights, as its next-gen leaders chart out fresh strategies to sustain its…
Bayer, Atara Biotherapeutics to partner for mesothelin-targeted CAR T-cell therapies EP News Bureau Dec 7, 2020 The agreement includes the development candidate ATA3271, an armored allogeneic T-cell immunotherapy, and an autologous version,…
Regenerative medicine market to reach $16.4 bn in 2026: GlobalData EP News Bureau Dec 5, 2020 There are currently 53 marketed RM products and 175 RM pipeline agents in development in the eight major markets
Three big-ticket deals contributed 69 per cent of total deal value in November 2020 EP News Bureau Dec 4, 2020 The healthcare industry reported 91 VC deals worth $3.3 billion in November 2020
Moderna to supply six million doses of COVID-19 vaccine to Israel EP News Bureau Dec 4, 2020 The company has already initiated the rolling regulatory review process with the Ministry of Health in Israel
Indifi forays into pharma segment along with Marg ERP EP News Bureau Dec 4, 2020 Indifi will be extending its credit line solution to pharma distributors and local chemists for managing their working capital…
Merck KGaA signs deal with Artios Pharma for cancer drugs research Reuters Dec 4, 2020 Artios will receive $30 million in up-front and near-term payments, plus double-digit option fees and up $860 million total…